This meeting will be fully dedicated to Interleukin-2 biology and therapeutic use. Please note that registration fees are applicable (see link below).
Many prestigious speakers have already confirmed their participation:
Abul K. Abbas, Andre Ballesteros-Tato, Christophe Benoist, Jeffrey Bluestone, Jen Bon Lui, Onur Boyman, Michael Farrar, Jason Fontenot, Agnes Hartemann, Jens Humrich, David Klatzmann, John Koreth, Vijay Kuchroo, Claude Le Pen, Zhanguo Li, Thomas Malek, Encarnita Mariotti-Ferrandiz, Alexander Marson, Robert Plenge, Jerome Ritz, Michelle Rosenzwajg, Alberto Sanchez-Fueyo, Scott Snapper, Naomi Taylor, Nadia Tchao, Georges Tsokos, Harikesh Wong, Adrian Woolfson, Jonathan Zalevsky, Zinan Zhang
This meeting is organized as part of the RHU iMAP project, financed by the ANR’s Plan d’Investissement d’Avenir, it will take place from the 13th to the 16th of November 2019 at the Centre International de Conférences de Sorbonne Université in Paris, France
During this meeting you will have the opportunity to know more about the mechanistic and clinical developments of wild-type and mutated IL-2 in different pathologies, but also about Treg based cell-therapies and the medical and economic impacts of these new immunotherapies.
To know more about this meeting and/or register please follow the link below:
https://www.il-2-2019.com
